Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS 753 is an agonist of isotype-selective retinoic acid receptor α (RARα, Ki= 2 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 163.00 | |
25 mg | In stock | $ 372.00 | |
50 mg | In stock | $ 597.00 | |
100 mg | In stock | $ 852.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | BMS 753 is an agonist of isotype-selective retinoic acid receptor α (RARα, Ki= 2 nM). |
Targets&IC50 | RARα:2 nM (Ki) |
In vitro | In WT cells, BMS 753 can reduce RAR β Transcription level of 2 in a dose dependent mode. At RAR γ-/- cells, 100 nM of BMS 753 efficiently induces RAR β 2 Transcription. In contrast, in RAR α-/- In cells, up to 100 nM of BMS 753 can not activate RAR β 2[1]. |
Molecular Weight | 351.4 |
Formula | C21H21NO4 |
CAS No. | 215307-86-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45.0 mg/mL (128.1 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS 753 215307-86-1 Metabolism Retinoid Receptor BMS753 BMS-753 inhibitor inhibit